https://twitter.com/renalandurology/status/1747352527941562403Renal prognoses are better in patients with PR3 ANCA-associated vasculitis (AAV) than myeloperoxidase (MPO) AAV, study findings from #KidneyWk confirm. https://bit.ly/48U1nr0
— Renal & Urology News (@renalandurology) Jan 16, 2024
No comments:
Post a Comment